FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2509985995> ?p ?o ?g. }

• W2509985995 endingPage "908" @default.
• W2509985995 startingPage "904" @default.
• W2509985995 abstract "The aim of this study was to evaluate changes in proteinuria in dogs naturally infected with visceral leishmaniasis, following treatment with miltefosine (MLF) and allopurinol.Medical records of 40 dogs with leishmaniasis, treated with 2 mg/kg MLF every 24 h PO and 10 mg/kg allopurinol every 12 h for 28 days were reviewed. 20 dogs were included in the study, and clinical staging was performed following guidelines of the Canine leishmaniasis (CanL) Working Group, and dogs were categorized for proteinuria according to the International Renal Interest Society (IRIS) staging system. Clinical score, indirect fluorescent antibody test titer, serum total protein, gamma globulin (IgG), serum creatinine and urea concentration, and urine protein creatinine ratio (UP/C) were recorded at the time of diagnosis before the start of therapy (D0) and at the end of 28 days of therapy (D28).Following the CanL Working Group staging, all 20 dogs were classified as the clinical Stage C (Clinical disease) before and after the cycle of treatment. Before the cycle of therapy, dogs were categorized according to the IRIS staging system, as: 9/20 non-proteinuric (NP), 7/20 borderline proteinuric (BP), and 4/20 proteinuric (P). After treatment, 12/20 dogs were NP, 7/20 were BP, and 1/20 was P. There was a significant change in UP/C values before and after one cycle of treatment with MLF. In detail, after 28 days of therapy, 2 of 9 NP dogs became BP, 3 of the 7 BP dogs became NP, and 2 of the 4 P dogs became NP.This study showed a significant decrease in UP/C values occurred after one cycle of treatment with MLF and allopurinol in dogs naturally affected with CanL. This suggests that MLF does not increase proteinuria, and the use of MLF could be considered for the management of dogs with leishmaniasis, particularly in those with impaired renal function at the time of diagnosis." @default.
• W2509985995 created "2016-09-16" @default.
• W2509985995 creator A5060917291 @default.
• W2509985995 creator A5068714787 @default.
• W2509985995 creator A5076549743 @default.
• W2509985995 creator A5079465492 @default.
• W2509985995 date "2016-08-01" @default.
• W2509985995 modified "2023-10-13" @default.
• W2509985995 title "Proteinuria reduction after treatment with miltefosine and allopurinol in dogs naturally infected with leishmaniasis" @default.
• W2509985995 cites W116276269 @default.
• W2509985995 cites W1534215101 @default.
• W2509985995 cites W1772992353 @default.
• W2509985995 cites W1795735701 @default.
• W2509985995 cites W1963508090 @default.
• W2509985995 cites W1984594388 @default.
• W2509985995 cites W1985088770 @default.
• W2509985995 cites W2011453212 @default.
• W2509985995 cites W2026729702 @default.
• W2509985995 cites W2047369227 @default.
• W2509985995 cites W2048280807 @default.
• W2509985995 cites W2054881085 @default.
• W2509985995 cites W2076111518 @default.
• W2509985995 cites W2084420388 @default.
• W2509985995 cites W2092793728 @default.
• W2509985995 cites W2101255948 @default.
• W2509985995 cites W2115315447 @default.
• W2509985995 cites W2128166966 @default.
• W2509985995 cites W2137109737 @default.
• W2509985995 cites W2141208795 @default.
• W2509985995 cites W2143730240 @default.
• W2509985995 cites W2155215879 @default.
• W2509985995 cites W2170914805 @default.
• W2509985995 cites W2280057432 @default.
• W2509985995 cites W2287236283 @default.
• W2509985995 doi "https://doi.org/10.14202/vetworld.2016.904-908" @default.
• W2509985995 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5021843" @default.
• W2509985995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27651682" @default.
• W2509985995 hasPublicationYear "2016" @default.
• W2509985995 type Work @default.
• W2509985995 sameAs 2509985995 @default.
• W2509985995 citedByCount "15" @default.
• W2509985995 countsByYear W25099859952016 @default.
• W2509985995 countsByYear W25099859952018 @default.
• W2509985995 countsByYear W25099859952019 @default.
• W2509985995 countsByYear W25099859952020 @default.
• W2509985995 countsByYear W25099859952021 @default.
• W2509985995 countsByYear W25099859952022 @default.
• W2509985995 countsByYear W25099859952023 @default.
• W2509985995 crossrefType "journal-article" @default.
• W2509985995 hasAuthorship W2509985995A5060917291 @default.
• W2509985995 hasAuthorship W2509985995A5068714787 @default.
• W2509985995 hasAuthorship W2509985995A5076549743 @default.
• W2509985995 hasAuthorship W2509985995A5079465492 @default.
• W2509985995 hasBestOaLocation W25099859951 @default.
• W2509985995 hasConcept C126322002 @default.
• W2509985995 hasConcept C126894567 @default.
• W2509985995 hasConcept C141071460 @default.
• W2509985995 hasConcept C203014093 @default.
• W2509985995 hasConcept C2776555147 @default.
• W2509985995 hasConcept C2777625542 @default.
• W2509985995 hasConcept C2778689377 @default.
• W2509985995 hasConcept C2779561371 @default.
• W2509985995 hasConcept C2780091579 @default.
• W2509985995 hasConcept C2780261098 @default.
• W2509985995 hasConcept C2780306776 @default.
• W2509985995 hasConcept C2781257258 @default.
• W2509985995 hasConcept C2781417161 @default.
• W2509985995 hasConcept C71924100 @default.
• W2509985995 hasConcept C90924648 @default.
• W2509985995 hasConceptScore W2509985995C126322002 @default.
• W2509985995 hasConceptScore W2509985995C126894567 @default.
• W2509985995 hasConceptScore W2509985995C141071460 @default.
• W2509985995 hasConceptScore W2509985995C203014093 @default.
• W2509985995 hasConceptScore W2509985995C2776555147 @default.
• W2509985995 hasConceptScore W2509985995C2777625542 @default.
• W2509985995 hasConceptScore W2509985995C2778689377 @default.
• W2509985995 hasConceptScore W2509985995C2779561371 @default.
• W2509985995 hasConceptScore W2509985995C2780091579 @default.
• W2509985995 hasConceptScore W2509985995C2780261098 @default.
• W2509985995 hasConceptScore W2509985995C2780306776 @default.
• W2509985995 hasConceptScore W2509985995C2781257258 @default.
• W2509985995 hasConceptScore W2509985995C2781417161 @default.
• W2509985995 hasConceptScore W2509985995C71924100 @default.
• W2509985995 hasConceptScore W2509985995C90924648 @default.
• W2509985995 hasIssue "8" @default.
• W2509985995 hasLocation W25099859951 @default.
• W2509985995 hasLocation W25099859952 @default.
• W2509985995 hasLocation W25099859953 @default.
• W2509985995 hasLocation W25099859954 @default.
• W2509985995 hasLocation W25099859955 @default.
• W2509985995 hasLocation W25099859956 @default.
• W2509985995 hasOpenAccess W2509985995 @default.
• W2509985995 hasPrimaryLocation W25099859951 @default.
• W2509985995 hasRelatedWork W1139037058 @default.
• W2509985995 hasRelatedWork W2022268574 @default.
• W2509985995 hasRelatedWork W2077000196 @default.
• W2509985995 hasRelatedWork W2110789706 @default.
• W2509985995 hasRelatedWork W2115957392 @default.

• next